Pilot Value Evidence
SCRIMED packages buyer-ready value proof without overclaiming authority.
This surface converts synthetic value metrics into pilot packets with acceptance criteria, reviewer checkpoints, blocked claims, and audit hashes so buyers can understand measurable pilot potential without receiving ROI, revenue, clinical, production, or customer-activation claims.
Distribution boundary
Evidence packets are buyer-ready, but still synthetic and review-gated.
SCRIMED Pilot Value Evidence packages synthetic-only value metrics into buyer-ready pilot packets, acceptance criteria, reviewer checkpoints, and claim controls. It does not authorize live PHI, autonomous clinical care, diagnosis, treatment, prescribing, patient outreach, payer submission, EHR writeback, final imaging interpretation, production deployment, customer activation, certification claims, audited financial reporting, valuation assurance, revenue guarantees, profit guarantees, ROI guarantees, or binding commercial offers.
01phiAuthority: not-authorized-production-phi
02clinicalCareAuthority: not-authorized-live-care
03commercialAuthority: not-binding-commercial-offer
04customerActivationAuthority: not-customer-go-live-approval
05financialAuthority: not-audited-financial-report
06roiAuthority: not-roi-guarantee
07revenueAuthority: not-revenue-guarantee
08productionAuthority: not-production-authorized
09payerAuthority: not-authorized
10ehrWritebackAuthority: not-authorized
11certificationAuthority: not-certified
Evidence packets
Each packet has a buyer segment, pilot window, acceptance criteria, human review gate, and retained boundary.
Attach the highest-fit packet to a buyer segment, demo route, acceptance criteria, reviewer checkpoint, and no-authority distribution gate before external sharing.
30-day
Workflow discovery evidence packet
Turn documentation and missing-evidence pain into a measurable no-PHI discovery scope.
Clinical operations and CMIO
- Review gate: Clinical operations reviewer approval before buyer distribution.
- Commercial next step: Convert to paid workflow discovery assessment with retained no-live-care boundary.
- Boundary: Not an ROI guarantee, audited labor-savings report, or clinical outcome claim.
- Artifacts: workflow-baseline-proxy, agent-trace-diligence-proof
- Audit: scrimed-intel-4eedb12e
60-day
RCM documentation evidence packet
Show documentation completeness and denial-review readiness without payer submission.
RCM and prior authorization teams
- Review gate: RCM compliance reviewer approval.
- Commercial next step: Offer a review-gated RCM documentation readiness pilot.
- Boundary: No payer submission, billing submission, coverage determination, or reimbursement guarantee.
- Artifacts: prior-auth-evidence-map, agent-trace-diligence-proof
- Audit: scrimed-intel-06e19b9a
60-day
Patient access evidence packet
Show referral and follow-up risk visibility without patient outreach or scheduling authority.
Patient access and care coordination
- Review gate: Patient access lead and patient education reviewer approval.
- Commercial next step: Scope a patient engagement readiness pilot with no live outreach.
- Boundary: No live patient outreach, scheduling command, care-plan modification, or patient-specific medical advice.
- Artifacts: referral-delay-proof, patient-education-readability-proof
- Audit: scrimed-intel-16367de0
90-day
Interoperability diligence packet
Convert healthcare IT complexity into a standards, source-contract, and approval evidence map.
CIO, security, integration teams
- Review gate: Integration security reviewer and data governance owner approval.
- Commercial next step: Sell technical discovery before any connector implementation.
- Boundary: Not production connector approval, EHR writeback, raw schema review, or live PHI authorization.
- Artifacts: interoperability-readiness-matrix, agent-trace-diligence-proof
- Audit: scrimed-intel-6f810523
90-day
Investor diligence evidence packet
Turn product, proof, route, safety, and commercial readiness signals into a claims-safe diligence package.
Angel, strategic, private, clinic, and partner investors
- Review gate: Founder and qualified diligence reviewer approval before distribution.
- Commercial next step: Use as investor-readiness appendix and buyer-pilot proof map.
- Boundary: Not securities material, valuation assurance, investment advice, certification, or customer go-live approval.
- Artifacts: investor-proof-manifest, workflow-baseline-proxy, operations-capacity-signal-proof
- Audit: scrimed-intel-f4872eaa
Evidence artifacts
Artifacts preserve baseline proxies, target evidence, measurement plans, and blocked claims.
pilot-scope-ready
Workflow baseline proxy
Compare synthetic baseline artifact against the human-reviewed SCRIMED packet completion record.
Clinical operations reviewer - score 93
- Baseline: Synthetic current-state packet assembly time, missing evidence count, and reviewer burden.
- Target: Reviewer-gated SCRIMED packet with time proxy, missing-evidence map, and audit hash.
- Allowed: Pilot value hypothesis, demo proof, and workflow discovery.
- Blocked: ROI guarantee, staffing reduction guarantee, clinical outcome guarantee
- Proof routes: /healthcare-value-realization, /healthcare-optimization-command, /clinical-robustness-lab
review-ready
Prior authorization evidence map
Track evidence coverage, missing fields, source references, and reviewer signoff.
RCM compliance reviewer - score 94
- Baseline: Synthetic policy criteria mapped to incomplete symptoms, timing, and functional-status fields.
- Target: Human-reviewed completeness map with missing language and blocked-submission status.
- Allowed: Prior-auth readiness demo and internal packet QA.
- Blocked: payer submission authority, coverage determination, reimbursement guarantee
- Proof routes: /pilot-demo-commercial-readiness, /scrimed-clinical-benchmark-suite, /service-delivery
pilot-scope-ready
Referral delay proof packet
Measure synthetic time-to-review, missing packet detection, and owner assignment completeness.
Patient access lead - score 89
- Baseline: Synthetic referral queue with missing packet, provider-match, wait-time, and status drift signals.
- Target: Closed-loop synthetic status map with owner routing and reviewer escalation.
- Allowed: Access-center workflow demo and pilot scoping.
- Blocked: patient outreach authority, appointment scheduling authority, care-plan modification
- Proof routes: /scrimed-patient-context-gateway, /health-records, /healthcare-value-realization
external-approval-required
Interoperability readiness matrix
Score interface inventory, source contract completeness, security owner coverage, and blocked writeback controls.
Integration security reviewer - score 92
- Baseline: Synthetic HL7, FHIR, DICOM, X12, RIS, HIS, PACS, VPN, VM, database, and firewall map.
- Target: Connector readiness matrix with standards, authority blockers, and proof routes.
- Allowed: Integration discovery and technical diligence.
- Blocked: production connector approval, raw schema exposure, EHR writeback authority
- Proof routes: /enterprise-healthcare-infrastructure, /clinical-data-fabric, /scrimed-hybrid-retrieval
review-ready
Agent trace diligence proof
Score trace field completeness, policy decision coverage, blocked action clarity, and audit hash presence.
TrustOps reviewer - score 96
- Baseline: Synthetic agent run with missing policy decision, missing tool permission, or missing reviewer note.
- Target: Trace-complete run envelope with model, tool, latency, cost, policy, reviewer, and failure metadata.
- Allowed: AI governance diligence and pilot QA.
- Blocked: protected tenant execution proof without AAL2, security certification, breach guarantee
- Proof routes: /scrimed-llmops-observability, /scrimed-agent-governance, /scrimed-trustops
Claim controls
Reviewer checkpoints prevent sales, pilot, and investor packets from drifting into unsupported promises.
blocked phrase
ROI overclaim
ROI guarantee
synthetic value hypothesis with reviewer-gated measurement plan
- Required evidence: baseline proxy, target direction, proof route, and reviewer signoff
blocked phrase
Revenue overclaim
revenue guarantee
commercial readiness signal
- Required evidence: pilot scope, buyer segment, offer path, and retained boundary
blocked phrase
Clinical authority overclaim
clinical outcome guarantee
decision-support workflow readiness
- Required evidence: clinical reviewer checkpoint and no-live-care boundary
blocked phrase
Payer workflow overclaim
payer submission authority
draft documentation completeness review
- Required evidence: human review gate and blocked-submission state
blocked phrase
Integration overclaim
production connector approved
synthetic interoperability discovery complete
- Required evidence: standards map, approval owner, and no-writeback boundary
blocked phrase
Investor overclaim
valuation assurance
diligence readiness evidence
- Required evidence: dated proof manifest, risk register link, and qualified-review note
blocked phrase
Customer activation overclaim
customer activation authority
pilot-readiness packet prepared for review
- Required evidence: acceptance criteria, reviewer gate, and no-production-authorization header